KREUWEL, HUUB T.C.
15  Ergebnisse:
Personensuche X
?
1

Dosing and Timing Effects of Anti‐CD40L Therapy: Prediction..:

GADKAR, KAPIL G. ; SHODA, LISL K. M. ; KREUWEL, HUUB T. C....
Annals of the New York Academy of Sciences.  1103 (2007)  1 - p. 63-68 , 2007
 
?
2

The Virtual NOD Mouse: Applying Predictive Biosimulation to..:

ZHENG, YANAN ; KREUWEL, HUUB T. C. ; YOUNG, DANIEL L....
Annals of the New York Academy of Sciences.  1103 (2007)  1 - p. 45-62 , 2007
 
?
3

Mechanisms Mediating Anti‐CD3 Antibody Efficacy: Insights f..:

YOUNG, DANIEL L. ; RAMANUJAN, SAROJA ; KREUWEL, HUUB T.C....
Annals of the New York Academy of Sciences.  1079 (2006)  1 - p. 369-373 , 2006
 
?
 
?
8

Ontogeny of T cell tolerance to peripherally expressed anti..:

Morgan, David J. ; Kurts, Christian ; Kreuwel, Huub T. C....
Proceedings of the National Academy of Sciences.  96 (1999)  7 - p. 3854-3858 , 1999
 
?
9

Ontogeny of T Cell Tolerance to Peripherally Expressed Anti..:

Morgan, David J. ; Kurts, Christian ; Huub T. C. Kreuwel...
Proceedings of the National Academy of Sciences of the United States of America.  96 (1999)  7 - p. 3854-3858 , 1999
 
?
14

Long-term efficacy, safety, and tolerability of a subcutane..:

Kobayashi, Roger H ; Litzman, Jiří ; Melamed, Isaac...
Clinical and Experimental Immunology.  210 (2022)  2 - p. 91-103 , 2022
 
1-15